hydrazine has been researched along with Duncan Disease in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Borchiellini, A; Carli, G; d'Amore, ESG; Lucchini, E; Merli, M; Motta, G; Passamonti, F; Quaresimini, G; Rambaldi, A; Rodeghiero, F; Romano, A; Ruggeri, M; Santi, RM; Valeri, F; Visco, C; Volpetti, S | 1 |
| Alonso, A; Alonso, R; Alvarez-Román, MT; Arrieta-Cerdán, E; Bastida, JM; Bernat, S; Bolaños, E; Caparrós, I; Entrena, L; Fernández-Fuentes, F; García-Frade, J; Gómez-Nuñez, M; González-López, TJ; González-Porras, JR; Hernández-Rivas, JA; Lopez-Ansoar, E; Martínez-Badas, MP; Martínez-Robles, V; Olivera, P; Pascual, C; Pérez-Rus, G; Sánchez-González, B; Soto, I; Tenorio, M; Yera Cobo, M | 1 |
| Nakao, S | 1 |
1 review(s) available for hydrazine and Duncan Disease
| Article | Year |
|---|---|
[Recent issues and prospects of the treatment of aplastic anemia].
Topics: Anemia, Aplastic; Animals; Antilymphocyte Serum; Benzoates; Biomarkers; Cyclosporine; Drug Therapy, Combination; Herpesvirus 4, Human; Humans; Hydrazines; Immunosuppressive Agents; Lymphoproliferative Disorders; Prednisolone; Pyrazoles; Receptors, Thrombopoietin; Risk; Severity of Illness Index; Thrombopoietin | 2014 |
1 trial(s) available for hydrazine and Duncan Disease
| Article | Year |
|---|---|
Eltrombopag for immune thrombocytopenia secondary to chronic lymphoproliferative disorders: a phase 2 multicenter study.
Topics: Adult; Aged; Aged, 80 and over; Benzoates; Blood Platelets; Chronic Disease; Female; Humans; Hydrazines; Lymphoproliferative Disorders; Male; Middle Aged; Prospective Studies; Purpura, Thrombocytopenic, Idiopathic; Pyrazoles | 2019 |
1 other study(ies) available for hydrazine and Duncan Disease
| Article | Year |
|---|---|
Use of eltrombopag for secondary immune thrombocytopenia in clinical practice.
Topics: Adult; Aged; Autoimmune Diseases; Benzoates; Drug Administration Schedule; Female; Humans; Hydrazines; Lymphoproliferative Disorders; Male; Middle Aged; Platelet Count; Purpura, Thrombocytopenic, Idiopathic; Pyrazoles; Receptors, Thrombopoietin; Retrospective Studies; Virus Diseases | 2017 |